Table 5.
Citation | Cell Line | Concentration of EPA or DHA (µM) | Ratio EPA:DHA | Assay | Change in Cell Viability * | Exposure (Hours) | Form of n-3 LCPUFA |
---|---|---|---|---|---|---|---|
Schley, Jijon, Robinson and Field [29] | MDA-MB-231 | 60 EPA + 40 DHA | 1.5:1 | TBE | ↓40% | 72 | Dissolved in ethanol |
45 EPA + 30 DHA + 75 LA | ↓31% | ||||||
Schley, Brindley and Field [13] | MDA-MB-231 | 60 EPA + 40 DHA | 1.5:1 | TBE | ↓62% | 72 | Dissolved in ethanol |
45 EPA + 30 DHA + 75 LA | ↓48% | ||||||
Mansara, Deshpande, Vaidya and Kaul-Ghanekar [32] | MDA-MB-231 | 84–153 EPA + 56–102 DHA + 25–140 AA | 1.5:1 | TBE | ↓54%–↓82% | 24 | Conjugated to delipidated, endotoxin free BSA |
MTT | ↓15%–↓30% | ||||||
MCF-7 | 84–153 EPA + 56–102 DHA + 25–140 AA | 1.5:1 | TBE | ↓38%–↓81% | 24 | Conjugated to delipidated, endotoxin free BSA | |
MTT | ↓20%–↓30% |
EPA = eicosapentaenoic acid, DHA = docosahexaenoic acid; AA = arachidonic acid; TBE = Trypan Blue Exclusion; MTT = 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; “↓” denotes significant decrease (p < 0.05); “%” = percent change from control condition; BSA = bovine serum albumin.; * Relative to control conditions.